Determinants of Severity of Coronary Artery
Disease in Australian Men Methods and Resuls To determine factors predictive of severity of CAD and of angina pectoris, we documented atherogenic variables and the extent of CAD at angiography in 594 consecutively studied men and women aged 65 years or less. Severity was assessed from the number of involved major coronary arteries with significant (>50%) luminal obstructions and from a coronary disease severity score. We related severity to quantitative and categorical atherogenic variables and assessed severity of angina (no angina, stable angina, or unstable angina) at the time of study in the same way. There were eight variables independently predictive of severity: in descending order of relative importance, male gender, diabetes, smoking dose, ratio of total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C), lipoprotein(a) [Lp(a)], age, positive family history, and hypertension. These correctly classified 43.3% of patients into no-, one-, two-, and threevessel disease categories and accounted for 25 Since World War II, there has been a concentration of effort in developed countries to define factors associated with increased risk of coronary artery disease (CAD) with the aim of implementing effective prevention. As recently reviewed,'-5 it is known that increased levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein (apo) B, lipoprotein(a) [Lp(a)], and possibly triglycerides (TG), as well as low levels of high-density lipoprotein cholesterol (HDL-C) and apo A-I, are associated with increased coronary risk; so are diabetes, hypertension, smoking, and a positive family history of premature CAD. Prospective studies have correlated these factors with coronary events. 4, 6, 7 However, few studies have examined the relation between these variables and the severity of CAD, as documented by its extent anatomically and clinically according to the severity of angina. This is particularly so for studies in women. Although left ventricular function is an important determinant of long-term outcome in patients with CAD, so also is the extent of the anatomic atherosclerotic involvement8 and the presence of stable versus unstable angina. 8.9 In the present study, we aimed to define in Australian men and women with premature CAD the relation between potentially atherogenic variables, both categorical and quantitative, and the extent of major vessel CAD and the severity of angina.
Methods Patient Population
We studied consecutive patients aged 65 years or less, both men and women, who were referred to the Prince Henry Hospital for coronary angiography over a 1-year period during 1991 and 1992 excluding only patients shown to have significant (>50% luminal obstruction) left main disease because it was difficult to categorize this small proportion of the total (<5%) within the classification system we used (see below). Consent was obtained from each patient for the study, which was approved by the Ethics Committee of the University of New South Wales. A 10-mL venous blood sample was drawn before the angiogram after a 4-to 6-hour fast, and the plasma interassay and intra-assay coefficients of variations were 5.1% and 8.2% for the apo A-I assay, 4.0% and 6.6% for the apo B assay, and 3.5% and 5.2% for Lp(a), respectively. The necessary assumptions were checked before the discriminant analysis was conducted. After levels of TG and Lp(a) were logarithmically transformed, all continuous independent variables had multivariate normal distributions in each of the four patient subgroups. The covariance matrices of all four patient groups were also not different as tested by Box's M test. In the analysis, independent variables are entered into the model, one at each step in descending order of minimizing the sum of unexplained variance. This model enables us to predict CAD severity from the identified independent risk factors and to assess the validity of predictions by comparing them with the actual CAD severity determined at angiography. We assessed this from the percentage of patients correctly predicted to have either no-, one-, two-, or threevessel disease. We also used multiple least-squares linear regression analysis to explore relations between the continuous (Green Lane) coronary severity scores and lipid variables, with the categorical factors being controlled separately. All statistical analyses were executed with the sPss statistical software package.
Patient Histories
The study was approved by the Ethics Committee of the University of New South Wales.
Results
Relation Between the Number of Significantly Diseased (>50%') Vessels and Independent
Risk Factors
Five hundred ninety-four patients were entered into the study-427 men and 167 women, of whom 358 men and 91 women had at least one major coronary artery with a significant obstruction (>50%). There were no significant differences in age, body mass index (BMI), or lipid levels between the men and women except for TG and ratio of TC to HDL-C, which were higher in men (P<.01 and P<.0001, respectively), and for HDL-C, which was lower in men (P<.0001). The patient data in relation to age, BMI, and lipid variables for each of the four severity subgroups are shown in Table 1 . There are no significant differences in age, BMI, and apo A-I among patients with different numbers of diseased vessels, and although there are increases in the levels of TC, LDL-C, apo B, and ratio of apo B to apo A-I with the increase in number of diseased vessels, the differences are also not statistically significant. By using ANOVA, there are significant differences in the ratio of TC to HDL-C (F= 10.46, P=.00001), HDL-C (F=8.73, P=.00001), log-TG (F=6.29, P=.0001), and log-Lp(a) (F=5.486, P=.001) for patients with different numbers of diseased vessels. However, except for Lp(a) levels, these differences are mainly between patients with significant disease and those without significant disease and not between patients with one-, two-, or threediseased vessels. Lp(a) levels are higher in patients with two or three diseased vessels than in those with only one diseased vessel (P=.004) or no significant vessel disease (P=.001).
The relations between patients with diabetes, hypertension, or positive family history of premature CAD and number of significantly diseased vessels were assessed by Pearson x2 analysis, as shown in Table 2 As shown in Table 3 , there is a very strong positive relation between lifetime cigarette consumption and CAD severity (X2=66.97, P=.000001). When we subgrouped patients according to current and past smoking habit by linking together current light, medium, and heavy smokers into a single group and ignoring total lifetime cigarette consumption, as illustrated in Table 3 , there was no statistically significant difference in CAD severity between ex-smokers and current smokers (X2=4.38, P=.222).
We documented patients receiving lipid-lowering and 3-adrenergic-blocking agents to explore the confounding effects of drug administration. Only 90 patients were taking lipid-lowering drugs, but 310 were receiving 13-adrenergic-blocking agents. As expected, the 90 patients taking lipid-lowering drugs had lower LDL-C levels (P<.001), lower ratios of apo B to apo A-I (P<.001), and lower ratios of TC to HDL-C (P<.01) but slightly higher TG (P<.05) than patients not taking them. The 310 patients receiving ,3-adrenergic-blocking drugs had a lower HDL-C (1.06±0.3 versus 1.13±0.36, P<.01) and higher log-TG (0.33+±0.21 versus 0.28±0.22, P<.01). Apo A-I was also lower in the 3-blocker users (1.19±0.37 versus 1.26±0.43, P<.05).
Determinants of CAD Severity
We used discriminant analysis to evaluate possible interactive effects among risk factors, their independent associations with severity, and their relative importance in predicting severity. The number of significantly diseased vessels was the dependent variable. When all 594 patients were included in the analysis, eight indepen- 
Discussion
The findings of the present study relate to a representative group of consecutively investigated patients determined by cardiologists to require angiography. Thus, the variables associated with disease severity and the strength of associations we found may differ from patterns in the general population. For example, there may be a bias toward angiography in patients with atypical chest pain and a low likelihood of disease if the patient is also a long-term cigarette smoker. This would inflate the perceived extent of smoking in patients without disease or with only mild disease, and the actual relation between cigarette smoking and CAD severity in the general population may be stronger than seen in our data. The same bias could occur in patients with a positive family history of premature CAD and atypical chest pain and lead to our data underestimating the association between severity and a positive family history. On the other hand, the incidence of significant CAD will be much lower in the general population than in our patient group, and the relation between risk factors and severity of disease will be less than noted here. Despite these considerations, the results of a recently reported World Health Organization Monica Project (relating to a large general population aged 35 to 69 years in an adjacent region, from which some of our patients were referred) are consistent with ours in relation to the three risk factors assessed in that study. In patients without a previous CAD history, smoking was a stronger predictor of first acute myocardial infarction or fatal heart attack than hypertension or cholesterol. 17 A further problem is the confounding effect of lipidlowering drug use in 90 patients and 3-adrenergic blockers in 310 patients. The former would attenuate relations between lipids and disease severity, and the latter could enhance the effects of elevated TG and low HDL-C. Therefore, it was reassuring to find associations of the same distribution and order of magnitude in patients not receiving these drugs as those for the entire patient population and improved predictive power (~10%), even though the sample size was greatly reduced. Nevertheless, confining the analysis to patients not taking these drugs decreases the spectrum of patients for whom disease severity is being assessed, and a degree of epidemiological bias remains. Despite these inherent limitations, the study defines strong correlations with disease severity that could be relevant to secondary rather than to primary mechanisms of atherogenesis and to prevention. An important aim of the present study was to compare factors associated with severity in men and women, and some differences did emerge. It is known that women in the general population in the age group of our study have higher HDL-C and apo A-I levels than men of the same age.19'20 This is also true for our coronary population. Although diabetes, smoking dose, ratio of TC to HDL-C (or HDL-C), Lp(a), hypertension, and a positive family history were significant predictors in both sexes, Lp(a) was more important in men and smoking dose was more important in women. TG was predictive in women but not in men, in whom TG was actually higher. Also, the combined effect of all independent variables was more predictive in women than in men. We have no explanation for these differences. However, the more powerful association of lifetime smoking dose with severity in women than in men was also seen in the large Australian population study of the occurrence of CAD17 (referred to above). Additional explanation for our finding comes from the unequal distribution of heavy smokers in our study population -60% of men and 39% of women -which would tend to diminish the calculated smoking effect in men.
Smoking and CAD Severity
The relation between lifetime smoking history and severity of CAD and angina irrespective of current smoking habit is the finding in this study that is most relevant to the population approach to coronary prevention. Although it has been clearly demonstrated that within 1 or 2 years of stopping smoking the risk of subsequent coronary events declines,21-23 the present study clearly shows that total smoking dose is the variable most predictive of the extent of the structural change, rather than current or ex-smoking status. Our result is also in accordance with the findings of Weintraub et al13 in their evaluation of male patients at angiography. However, that investigation did not assess the strength of the association in relation to the contributions of other variables.
Ambrose et a124 showed in a longitudinal study of coronary patients that less-severe (<50%) luminal obstructions may frequently be the culprit lesions for later myocardial infarction and total coronary occlusion. Smoking cessation may diminish the likelihood of such events by reducing the propensity for platelets to aggregate24 and therefore the likelihood of unstable angina or acute myocardial infarction and explain the associated improved coronary event rate. Nevertheless, it is logical to expect long-term structural change as a consequence of total cigarette consumption by thrombogenic mechanisms, and perhaps by lowering HDL-C,25,26 and for these changes to occur progressively over many years. The present data provide a powerful argument for di-recting antismoking programs toward the young, 30% of whom smoke regularly in Australia. 27 
Lipids and CAD Severity
Of all the lipid variables we measured, whether they were analyzed in relation to CAD severity in all patients or in the various subgroups of patients investigated, high ratio of TC to HDL-C (or low HDL-C) and high Lp(a) were consistently highly significant predictors of severity. TC, LDL-C, apo B, apo A-I, and ratio of apo B to apo A-I were much less predictive. This suggests that factors predicting the occurrence of CAD may not necessarily be of the same importance as those associated with CAD severity. In general, ratio of TC to HDL-C could be substituted for HDL-C and had slightly more predictive power than low HDL-C.
Circulating levels of Lp(a) are more closely genetically regulated than any of the other lipid variables we measured.28 When we assessed the quantitative variables and CAD severity using the coronary score in linear regression analyses in patients with and without a family history of premature CAD, the Lp(a) level was the only significant factor associated with the coronary score (r=.206, P=.011) in the former and the HDL-C level was the only factor associated (negatively) with the coronary score in the latter (r=.222, P=.007). The finding of Durrington et a129 that Lp(a) levels could be substituted for a positive family history of premature CAD in male subjects after myocardial infarction is consistent with the present data, which suggest that Lp(a) is an important mediator of the family history contribution to coronary risk and to severity of CAD.
The contribution of high Lp(a) levels to the severity of disease also emerged from findings in patients with unstable angina. These patients had higher coronary scores and higher Lp(a) levels than those with stable angina. They also were more likely to have a positive family history of CAD or a history of hypertension or diabetes. Thus, as a group, they clearly had more-severe disease. Because platelet aggregation and thrombus formation associated with plaque rupture appear to be the usual mechanisms mediating a change from stable to unstable angina,9 the likelihood of elevated Lp(a) reducing the efficacy of thrombolysis30 may be of particular importance in this relatively acute situation.
In summary, this study of severity of CAD in men and women aged 65 years or less identifies a hierarchy of factors different in some respects from that known to be associated with the occurrence of CAD. It also substantiates an association with severity for other factors known to be predictive of increased cardiovascular risk (eg, diabetes, hypertension, male gender, and age). Of particular importance for preventive medicine is the clear association between severity and total smoking dose irrespective of current smoking habit and of its relatively greater importance in women. The study also defines an overriding importance of HDL-C, expressed as ratio of TC to HDL-C or as HDL-C, and of Lp(a) in the severity of CAD. At present, it is difficult to lower elevated Lp(a) except through the use of estrogens in postmenopausal women31,32 and high-dose nicotinic acid.33 However, dietary change, weight reduction in the obese, exercise, and, when indicated, statins, fibric acid derivatives, nicotinic acid, and lipid-lowering resins, used appropriately, all have a potential for improving ratio of TC to HDL-C and HDL-C levels. Also, recent studies indicate that these measures may stabilize progression of CAD and, in some instances, induce regression. [34] [35] [36] 
